Last year, the University saw its sponsored program awards increase from $486.8 million to $579.4 million. The support came from such agencies and organizations as the National Science Foundation, the US Department of Defense, the National Institutes of Health, and the National Cancer Institute, to name a few. Read on to see how some of the money is being used.
- Professors of Epidemiology Elizabeth Hatch and Lauren Wise, and their team of researchers in the Department of Epidemiology, received two grants totaling close to $6 million from the National Institute of Environmental Health Sciences of the National Institutes of Health to expand their research on fertility and miscarriage.
- Researchers from the College of Engineering and Boston Medical Center were awarded a three-year, $900,000 National Science Foundation grant to develop and pilot a health informatics system to predict patients at risk of heart disease or diabetes, and enable early intervention and personalized treatment.
- The African Studies Center was awarded National Resource Center and Foreign Language and Area Studies grants from the United States Department of Education, more than $2.2 million over four years, to support Africa-focused education, including instruction in African languages.
- A BU-led research team was selected to receive a $7.5 million, six-year Multidisciplinary University Research Initiative grant from the US Department of Defense to create neuro-autonomous robots.
- BU School of Medicine researchers were awarded a $4.9 million Massachusetts Life Sciences Capital grant to develop new brain imaging techniques to better understand diseases like CTE and Alzheimer’s.
- Health economist Rena Conti, a researcher at BU’s Institute for Health System Innovation & Policy and associate professor at Questrom School of Business, is conducting a $600,000 study to better understand the range of financial difficulties experienced by patients undergoing cancer treatments, particularly in minority and/or underserved communities. The research is being funded by the Alliance for Clinical Trials in Oncology, the Leukemia & Lymphoma Society, and the National Cancer Institute.